title: Raising the roof: the preferential pharmacological stimulation of Th1 and th2 responses mediated by NKT cells.
abstract: Natural killer T (NKT) cells serve as a bridge between the innate and adaptive immune systems, and manipulating their effector functions can have therapeutic significances in the treatment of autoimmunity, transplant biology, infectious disease, and cancer. NKT cells are a subset of T cells that express cell-surface markers characteristic of both natural killer cells and T cells. These unique immunologic cells have been demonstrated to serve as a link between the innate and adaptive immune systems through their potent cytokine production following the recognition of a range of lipid antigens, mediated through presentation of the major histocompatibility complex (MHC) class I like CD1d molecule, in addition to the NKT cell's cytotoxic capabilities upon activation. Although a number of glycolipid antigens have been shown to complex with CD1d molecules, most notably the marine sponge derived glycolipid alpha-galactosylceramide (α-GalCer), there has been debate as to the identity of the endogenous activating lipid presented to the T-cell receptor (TCR) via the CD1d molecule on antigen-presenting cells (APCs). This review aims to survey the use of pharmacological agents and subsequent structure-activity relationships (SAR) that have given insight into the binding interaction of glycolipids with both the CD1d molecules as well as the TCR and the subsequent immunologic response of NKT cells. These studies not only elucidate basic binding interactions but also pave the way for future pharmacological modulation of NKT cell responses.
authors.affiliation: Department of Microbiology and Immunology, The Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland 21201.
authors.forename: James E
authors.initials: JE
authors.lastname: East
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Kennedy
authors.forename: Tonya J
authors.initials: TJ
authors.lastname: Webb
mesh_terms: D000818:Animals; D002240:Carbohydrate Sequence; D005699:Galactosylceramides / Q000737:chemistry / Q000494:pharmacology; D006017:Glycolipids / Q000276:immunology; D006801:Humans; D007694:Killer Cells, Natural / Q000187:drug effects* / Q000276:immunology; D008969:Molecular Sequence Data; D013329:Structure-Activity Relationship; D018417:Th1 Cells / Q000187:drug effects* / Q000276:immunology; D018418:Th2 Cells / Q000187:drug effects* / Q000276:immunology
chemical_list: D005699:Galactosylceramides; D006017:Glycolipids; C493154:alpha-galactosylceramide